Terms: = Uterine cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Prognosis
20 results:
1. The potential mechanism of Guizhi Fuling Wan effect in the treatment of cervical squamous cell carcinoma: A bioinformatics analysis investigation.
Wang X; Wang T; Jiang X; Ruan Y; Wang J; Qi C
Medicine (Baltimore); 2024 Feb; 103(5):e37153. PubMed ID: 38306566
[TBL] [Abstract] [Full Text] [Related]
2. Physical interaction between STAT3 and ap1 in cervical carcinogenesis: Implications in HPV transcription control.
Thakur K; Janjua D; Aggarwal N; Chhokar A; Yadav J; Tripathi T; Chaudhary A; Senrung A; Shrivastav A; Bharti AC
Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166817. PubMed ID: 37532113
[TBL] [Abstract] [Full Text] [Related]
3. The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry.
Chu T; Meng Y; Wu P; Li Z; Wen H; Ren F; Zou D; Lu H; Wu L; Zhou S; Chen Y; Li J; Xu M; Wu X; Xiong X; Wang Z; He M; Zhang Y; Lin S; Cao C; Ding W; Chen Y; Zhi W; Peng T; Wei Y; Liu B; Xu Y; Ma D; Wang J; Sun C; Wu P
Lancet Oncol; 2023 Jun; 24(6):701-708. PubMed ID: 37269846
[TBL] [Abstract] [Full Text] [Related]
4. Bioinformatic Analysis of miR-200b/429 and Hub Gene Network in Cervical cancer.
Shukla V; Mallya S; Adiga D; Sriharikrishnaa S; Chakrabarty S; Kabekkodu SP
Biochem Genet; 2023 Oct; 61(5):1898-1916. PubMed ID: 36879084
[TBL] [Abstract] [Full Text] [Related]
5. Human Papillomavirus Modulates Matrix Metalloproteinases During Carcinogenesis: Clinical Significance and Role of Viral Oncoproteins.
Mendonça F; Teles AM; Nascimento MDDSB; Santos APAD; Lopes FF; Paiva A; Brito HO; DA Costa RG
In Vivo; 2022; 36(6):2531-2541. PubMed ID: 36309355
[TBL] [Abstract] [Full Text] [Related]
6. RacGap1 promotes the malignant progression of cervical cancer by regulating AP-1 via miR-192 and p-JNK.
Zhang T; Wang C; Wang K; Liang Y; Liu T; Feng L; Yang X
Cell Death Dis; 2022 Jul; 13(7):604. PubMed ID: 35831303
[TBL] [Abstract] [Full Text] [Related]
7. Genistein induces long-term expression of progesterone receptor regardless of estrogen receptor status and improves the prognosis of endometrial cancer patients.
Yoriki K; Mori T; Aoyama K; Tarumi Y; Kataoka H; Kokabu T; Kitawaki J
Sci Rep; 2022 Jun; 12(1):10303. PubMed ID: 35717540
[TBL] [Abstract] [Full Text] [Related]
8. The effect of consolidation chemotherapy after concurrent chemoradiation on the prognosis of locally advanced cervical cancer: a systematic review and meta-analysis.
Zhong L; Li K; Song L; Yin R
J Obstet Gynaecol; 2022 Jul; 42(5):830-837. PubMed ID: 35148230
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancer.
Wang M; Xue Y; Shen L; Qin P; Sang X; Tao Z; Yi J; Wang J; Liu P; Cheng H
Redox Biol; 2019 Jun; 24():101225. PubMed ID: 31136958
[TBL] [Abstract] [Full Text] [Related]
10. A gene interaction network‑based method to measure the common and heterogeneous mechanisms of gynecological cancer.
Wang M; Li L; Liu J; Wang J
Mol Med Rep; 2018 Jul; 18(1):230-242. PubMed ID: 29749503
[TBL] [Abstract] [Full Text] [Related]
11. RBBP6 promotes human cervical carcinoma malignancy via JNK signaling pathway.
Teng F; Ruan HJ; Xu J; Ni J; Qian B; Shen R; Gao LJ
Biomed Pharmacother; 2018 May; 101():399-405. PubMed ID: 29501043
[TBL] [Abstract] [Full Text] [Related]
12. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract] [Full Text] [Related]
13. CD24 promotes the proliferation and inhibits the apoptosis of cervical cancer cells in vitro.
Pei Z; Zhu G; Huo X; Gao L; Liao S; He J; Long Y; Yi H; Xiao S; Yi W; Chen P; Li X; Li G; Zhou Y
Oncol Rep; 2016 Mar; 35(3):1593-601. PubMed ID: 26707501
[TBL] [Abstract] [Full Text] [Related]
14. Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.
Yu CG; Jiang XY; Li B; Gan L; Huang JF
Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913
[TBL] [Abstract] [Full Text] [Related]
15. [Effects of postoperative chemotherapy on the prognosis of patients with high-risk early stage endometrial cancer].
Wen HW; Tian F; Ma L; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2009 Mar; 44(3):196-9. PubMed ID: 19570445
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].
Tang L; Zheng M; Xiong Y; Ding H; Liu FY
Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034
[TBL] [Abstract] [Full Text] [Related]
17. [Effects of chemotherapy in recurrent endometrial carcinoma].
Wang ZQ; Wang JL; Liu FT; Zhao D; Gao M; Wei LH
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):896-900. PubMed ID: 16759515
[TBL] [Abstract] [Full Text] [Related]
18. Value of glutathione S-transferase pi and the oncogene products c-jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas.
Yokoyama Y; Sagara M; Sato S; Saito Y
Gynecol Oncol; 1998 Mar; 68(3):280-7. PubMed ID: 9570981
[TBL] [Abstract] [Full Text] [Related]
19. [Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix].
Petrov SV; Mazurenko NN; Sukhova NM; Moroz IP; Katsenel'son VM; Raĭkhlin NT; Kiselev FL
Arkh Patol; 1994; 56(4):22-31. PubMed ID: 7848100
[TBL] [Abstract] [Full Text] [Related]
20. No correlation between ras, c-myc and c-jun proto-oncogene expression and prognosis in advanced carcinoma of cervix.
Symonds RP; Habeshaw T; Paul J; Kerr DJ; Darling A; Burnett RA; Sotsiou F; Linardopoulos S; Spandidos DA
Eur J Cancer; 1992; 28A(10):1615-7. PubMed ID: 1389474
[TBL] [Abstract] [Full Text] [Related]
